Nevada AB411 revises prescription drug labeling to allow health care practices to be named instead of individual practitioners for certain drugs.
Nevada AB411 modifies the labeling requirements for prescription drugs, specifically for mifepristone, misoprostol, or their generic alternatives. Upon request from the prescribing practitioner, the label must include the name of the prescribing health care practice instead of the individual practitioner. The label must also include the date, the name, address, and prescription serial number of the practitioner who filled the prescription, the number of dosage units, the symptom or purpose for which the drug is prescribed, specific directions for use, the expiration date of the drug, the.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.